Authors N.H., M.O., Y.T., Y.A., Y.S., H.H., P.B.L., A.I.J., T.K., S.M., T.H., T.I., N.G., C.S., H.I., and R.Y
2 Digital care and dosing for GLP-1 therapy One of the most promising innovations in obesity management is the integration of digital coaching with flexible medication dosing
With the right dietary changes and medical guidance, you can minimize discomfort
The choice between injectable and sublingual delivery is ultimately a clinical and personal preference decision made in consultation with the reviewing provider
The review is the first to compare efficacy of the three FDA-approved GLP-1 medications in non-diabetic patients using the drugs for weight loss
Clear communication ensures safe transitions and supports optimal glycemic control